| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
HCW Biologics Inc. Common Stock (NASDAQ: HCWB)
HCWB Technical Analysis
5
| As on 9th Jun 2023 HCWB STOCK Price closed @ 2.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.31 & Strong Sell for SHORT-TERM with Stoploss of 2.28 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HCWBSTOCK Price
| Open | 2.09 | Change | Price | % |
| High | 2.18 | 1 Day | -0.13 | -6.05 |
| Low | 1.98 | 1 Week | 0.37 | 22.42 |
| Close | 2.02 | 1 Month | 0.62 | 44.29 |
| Volume | 68200 | 1 Year | -0.72 | -26.28 |
| 52 Week High 3.17 | 52 Week Low 1.12 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HCWB Daily Charts |
HCWB Intraday Charts |
Whats New @ Bazaartrend |
HCWB Free Analysis |
|
|
HCWB Important Levels Intraday
| RESISTANCE | 2.41 |
| RESISTANCE | 2.28 |
| RESISTANCE | 2.21 |
| RESISTANCE | 2.13 |
| SUPPORT | 1.91 |
| SUPPORT | 1.83 |
| SUPPORT | 1.76 |
| SUPPORT | 1.63 |
HCWB Forecast May 2024
| 4th UP Forecast | 3.5 |
| 3rd UP Forecast | 3.03 |
| 2nd UP Forecast | 2.73 |
| 1st UP Forecast | 2.44 |
| 1st DOWN Forecast | 1.6 |
| 2nd DOWN Forecast | 1.31 |
| 3rd DOWN Forecast | 1.01 |
| 4th DOWN Forecast | 0.54 |
HCWB Weekly Forecast
| 4th UP Forecast | 2.77 |
| 3rd UP Forecast | 2.53 |
| 2nd UP Forecast | 2.38 |
| 1st UP Forecast | 2.23 |
| 1st DOWN Forecast | 1.81 |
| 2nd DOWN Forecast | 1.66 |
| 3rd DOWN Forecast | 1.51 |
| 4th DOWN Forecast | 1.27 |
HCWB Forecast2024
| 4th UP Forecast | 6.34 |
| 3rd UP Forecast | 4.95 |
| 2nd UP Forecast | 4.1 |
| 1st UP Forecast | 3.24 |
| 1st DOWN Forecast | 0.8 |
| 2nd DOWN Forecast | -0.06 |
| 3rd DOWN Forecast | -0.91 |
| 4th DOWN Forecast | -2.3 |
HCW Biologics Inc. Common Stock ( NASDAQ USA Symbol : HCWB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HCWB Business Profile
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead product include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida. Address: 2929 North Commerce Parkway, Miramar, FL, United States, 33025
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service